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Abstract
Bi-directional communication with the microenvironment is essential for homing and sur-
vival of cancer cells with implications for disease biology and behaviour. In chronic lympho-
cytic leukemia (CLL), the role of the microenvironment on malignant cell behaviour is well
described. However, how CLL cells engage and recruit nurturing cells is poorly character-
ised. Here we demonstrate that CLL cells secrete exosomes that are nanovesicles originat-
ing from the fusion of multivesicular bodies with the plasma membrane, to shuttle proteins,
lipids, microRNAs (miR) and mRNAs to recipient cells. We characterise and confirm the
size (50–100 nm) and identity of the CLL-derived exosomes by Electron microscopy (EM),
Atomic force microscopy (AFM), flow cytometry and western blotting using both exosome-
and CLL-specific markers. Incubation of CLL-exosomes, derived either from cell culture
supernatants or from patient plasma, with human stromal cells shows that they are readily
taken up into endosomes, and induce expression of genes such as c-fos and ATM as well
as enhance proliferation of recipient HS-5 cells. Furthermore, we show that CLL exosomes
encapsulate abundant small RNAs and are enriched in certain miRs and specifically hsa-
miR-202-3p. We suggest that such specific packaging of miR-202-3p into exosomes results
in enhanced expression of ‘suppressor of fused’ (Sufu), a Hedgehog (Hh) signalling inter-
mediate, in the parental CLL cells. Thus, our data show that CLL cells secrete exosomes
that alter the transcriptome and behaviour of recipient cells. Such communication with
microenvironment is likely to have an important role in CLL disease biology.
Introduction
Chronic lymphocytic leukemia (CLL) is characterised by accumulation of monoclonal mature
B-lymphocytes in the circulation and tissues.[1, 2] The malignant lymphocytes depend on
micro-environmental cues and factors for accumulation and survival.[3, 4] A myriad of factors
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that support CLL cell growth and proliferation are described including secreted cytokines such
as IL6, IL21, and IL4, cell-contact elements such as CD40-CD154, and integrin-ligand interac-
tions.[3] These reports have mainly addressed the effects of the microenvironment on the phe-
notype of CLL cells. However, whether CLL cells can affect the behaviour and phenotype of
supportive cells within the stromal microenvironment is not widely addressed.
Cellular communication typically involves secreted factors and direct cell contact. Recent
studies have demonstrated an additional layer of intercellular communication involving the
secretion and uptake of extracellular vesicles (EVs).[5] Exosomes are a discrete population of
small (50–100 nm diameter) EVs of endosomal origin with a lipid membrane bilayer and a
cup-shaped morphology.[6] Exosomes encapsulate selected membrane and cytoplasmic pro-
teins and can influence the phenotype and behaviour of adjacent or distant cells through the
transfer of messenger and microRNAs (mRNA and miRs).[5, 7–9] Exosomes derived from
mouse mast cells are shown to deliver mRNA to human mast cells with the subsequent expres-
sion of murine proteins within the human recipient cells.[10] Successive studies demonstrate
similar exosome-mediated transfer of mRNA and miRs to other cells of the immune system,
including B cells, in order to modulate behaviour. Similarly, tumour derived exosomes modu-
late the microenvironment to promote disease progression in glioblastoma[11] and other can-
cers.[12–14]
With respect to CLL, microvesicles derived from the malignant cells in this disease are
shown to transfer the phospho-receptor tyrosine kinase Axl to stromal cells to create a “homing
and nurturing” environment.[15] Recent work has demonstrated the presence of miR-155
in microvesicles derived from the plasma of CLL patients with progressive disease.[16] This
is pertinent as miRs are critical for CLL pathogenesis and deregulated expression of miRs,
such as miR-155, segregates with aggressive phenotypes and poor prognosis.[17–19] So far,
direct transfer of CLL-derived miRs to cells in the microenvironment cells has not been
demonstrated.
Given that secreted exosomes facilitate intercellular communication and signalling, we
investigated the physical and functional characteristics of these vesicles released by CLL cells.
We explored the hypothesis that uptake of CLL derived exosomes can lead to reprogramming
of the transcriptional profile of recipient cells. Towards this end, we isolated exosomes from
CLL cell cultures and patient plasma. Characterisation of these exosomes showed that their
physical properties are consistent with those described for such EVs derived in other systems.
Examination of the effects of CLL-derived exosomes on human stromal cell behaviour showed
that these EVs perturb gene expression within, and enhance proliferation of, target recipient
stromal cells. Analysis of their miR cargo showed that CLL-derived exosomes have a unique
signature that is not merely a reflection of the miR content of the parental cells. More impor-
tantly, we demonstrate a selective enrichment of miR-202-3p in CLL exosomes. Thus, this
study a) provides evidence for exosome mediated communication of CLL cells with the micro-
environment and b) identifies a unique exosomal molecular content that is relevant in disease
biology.
Materials and Methods
Patient samples, cell lines, and cell culture
The collection and use of the primary patient material used in this study had approval from the
Liverpool Research Ethics committee. Primary mononuclear (CLL and normal B) cells from
fresh or viably frozen samples were purified by MACS isolation as previously described.[50] B-
cell purity (>95%) was assessed by flow cytometry. Only samples from untreated CLL patients
were included in this study (Table A in S1 File). CLL cells (2 x 107 cells/ml) were cultured in
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RPMI-1640 supplemented with 1% Bovine Serum Albumin (BSA), 2 mM L-glutamine, 100 U/
ml penicillin, and 100 μg/ml streptomycin (Invitrogen, UK). BSA was used to avoid potential
contamination with exosomes in foetal calf serum. MEC1 (CLL derived line)[51] and HS-5 (a
human BM cell line)[52] were cultured in RPMI medium.
Isolation of exosomes
CLL cells were cultured for 48h and media supernatant was harvested. Exosomes were purified
from this supernatant using the scheme illustrated (Figure A in S1 File), following the proce-
dure described by Thery et al.[20] with minor modifications. Following the final wash step, the
resultant pellet containing exosomes was resuspended in 30–50 μl PBS (or appropriate lysis
buffer), protein content was determined by Bradford assay and the suspension stored at -80°C
until used. An alternative method of isolating exosomes was also employed. This involved
incubating culture supernatants overnight with anti-HLA magnetic beads, and then capturing
the bound exosomes using a magnet (Dynal Biotech).[53]
Phenotypic and physical characterisation of exosomes
For surface protein expression analysis, exosomes prepared by ultracentrifugation were
adsorbed on to aldehyde-sulphate latex beads (3.8μm) (Molecular probes, Invitrogen) as
described.[20] Here 10μg of exosomes in 100μl PBS were incubated with 25μl bead suspension
overnight. The beads were washed, stained with antibodies of interest, and finally analysed by
flow cytometry (FACS Calibur; BD Biosciences).[54] For analysis by Western blotting,
exosome-associated proteins (5–10μg) solubilised in SDS-PAGE buffer were separated by elec-
trophoresis on polyacrylamide gels, and transferred to an immobilon solid support for chemi-
luminescent protein detection. The antibodies used are listed in Table B in S1 File. Further
physical characterization of isolated exosomes was achieved by two independent methods:
Transmission Electron microscopy. Exosome pellets isolated by ultracentrifugation were
fixed in 2% paraformaldehyde and adsorbed on to Formvar-carbon coated grids. These grids
were then fixed with 1% glutaraldehyde, contrasted in 2% uranyloxalate- / uranylacetate-meth-
ylcellulose solution and air-dried. When exosomes isolated by magnetic beads were used, these
were fixed in 2.5% (v/v) glutaraldehyde for 2 hrs before embedding them in 4% agar. The exo-
some-agar blocks were fixed with 1% osmium tetroxide (45 mins), and then stained with 2%
Uranylacetate (in 0.69% maleic acid). The blocks were dehydrated with washes of solution with
ascending ethanol concentration, and then embedded in epoxy resin (TAAB) for polymerisa-
tion (at 60˚C overnight). Ultrathin sections (90nm) were cut from this final preparation on a
Reichert-Jung ultramicrotome and stained with Reynold’s lead citrate (5 mins). Images were
viewed in a transmission electron microscope (Philips EM208S).
Atomic Force Microscopy (AFM). Five μg of purified exosomes in de-ionized H2O were
added to a freshly cleaved mica sheet and incubated for 10 min. The sheet was rinsed with de-
ionized H2O, and air-dried. A Multimode 8 atomic force microscope (Bruker), equipped with a
160-μm J-scanner and oxide-sharpened Si3N4 cantilevers (600μm, k = 0.4 Nm−1) was operated
in peak force tapping mode for imaging. Topographic height, DMT (Derjaguin-Muller-
Toporov) modulus and adhesion images were recorded simultaneously at 512×512 pixels (scan
rate = 1Hz). Image processing required NanoScope Analysis software (Bruker).
Exosome-labelling and immunofluorescence microscopy
Exosomes were fluorescently labelled using the PKH67 dye (Sigma-Aldrich) as previously
described.[33] Staining efficiency determined by FACS analysis was>90%. For uptake studies,
PKH67-labelled exosomes were seeded, in serum free media, on to a sub-confluent layer of
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HS-5 (5x105) cells adherent to a cover slip within a 24-well plate. Free PKH67 in diluent served
as control. After 2-hour incubation with exosomes or free dye, the culture media was changed
and cells allowed to proliferate overnight. Cells were then harvested, fixed with 4% paraformal-
dehyde, permeabilised with a 0.1% solution of Triton X-100, stained with primary antibody of
interest, followed by a fluorescent-tagged secondary antibody and counterstained with DAPI.
Resultant cell preparations were examined using an Olympus BX61 microscope (100X magni-
fication). Images were captured with a Photometrics Cool Snap HQ2 camera and MicroMan-
ager Software and were analyzed with Image J software (NIH).
RNA isolation, cDNA preparation, miR array analysis, RT-qPCR, and
miR transfections
Total RNA extractions were performed using the miRNeasy kit (Qiagen), and quantitatively
and qualitatively assessed using a Nanodrop ND-1000 (Nanodrop) and a Bio-analyser 2100
(Agilent). For miR expression analysis, fluorescence-labelled exosomal RNA (180 ng) and total
cellular RNA (1μg) samples were submitted for data acquisition (Exiqon miRCURYTM LNA
array v.5) and analysis (background subtraction and normalisation).
Reverse transcribed microRNA was prepared using a miScript II kit (Qiagen), and subjected
to RT-qPCR analysis using commercial primers (Qiagen) and miScript SYBR Green PCR Kit.
Analysis was carried out on an Mx3000P machine (Stratagene). miR expression was calculated
either by the standard curve method, or determined relative to RNU6B using the 2–ΔΔCt
method. Sufu and GAPDH primer sequences for mRNA expression analysis by RT-qPCR are
listed in Figure B in S1 File.
The HS-5 cell line was transfected with miR-202-3p mimic or scrambled control (Life tech-
nologies) using the Lipofectamine 2000 transfection reagent according to the manufacturer’s
protocol (Invitrogen). Cells were harvested for analysis after 24h.
Gene expression analysis of HS-5 cells incubated with exosomes was performed using the
Human Pathway Finder PCR array (Qiagen). Data analysis was performed using the software
provided (Qiagen). Fold changes in gene expression were calculated using GAPDH normalisa-
tion and the 2–ΔΔCt method. Results were verified independently by RT-qPCR. HS-5 cells
‘spiked’ with exosomes served as controls.
Assay for c-fos activity
Nuclear c-fos activity was quantified using a TransAM1 AP-1/c-fos ELISA assay kit (Active
motif) following the supplied protocol and a Gemini Fluorescence microplate reader (450 nm)
(Molecular Devices).
Cell proliferation
Relative cell numbers were assessed, after generation of a standard curve, using the CyQuant
NF cell proliferation assay kit (Invitrogen), following manufacturer’s instructions. Values were
normalised to untreated controls.
Results
Tumour derived exosomes exhibit physical characteristics that reflect
the derivation from parental CLL cells
Exosomes were isolated from cell culture supernatants after a series of ultracentrifugation steps
(Figure A in S1 File) as previously described.[20] Method optimisation was achieved using cul-
ture media from two B-cell lines [Raji (B-cell lymphoma) and MEC-1 (CLL derived)], and
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applied to culture supernatants of freshly isolated CLL cells (purity and viability>95%) that
were cultured for 48h in RPMI-1640 medium supplemented with 1% BSA but not serum to
avoid potential contamination by exogenous exosomes. We next characterised these CLL cell-
derived exosomes for their phenotypic and physical properties.
To investigate the size and typical morphological characteristics of the isolated exosomes,
we undertook transmission electron microscopy (TEM) analysis. Fig 1A (upper panel)
shows that the harvested CLL exosomes derived using our ultracentrifugation protocol have
typical contours (cup-shaped morphology) and size (50–100 nm) consistent with an exosome-
specific phenotype. For additional confirmation, we then employed a second method of isola-
tion in which CLL exosomes were purified using anti-HLA magnetic beads. Here, TEM
analysis of ultrathin sections of agar embedded beads showed that the exosomes had similar
Fig 1. Characterization of CLL derived exosomes. A) Transmission electron microscopy (TEM) image of exosomes enriched from CLL cell culture
medium after 48 hrs. (a) Exosomes are visible as small 50–100 nm vesicles with bi-layered membranes (scale bar: 100 nm). (b) Exosomes were immune-
isolated using magnetic beads coated with anti-HLA antibody and ultrathin sections of resultant beads processed for image analysis. The representative
TEM image shows a bead coated with exosomes (scale bar: 0.2μm). B) AFM images of exosomes from a representative CLL case immobilized on a mica
surface using Peakforce Tapping mode (Multimode 8, Bruker). A) Topographic image of exosomes.B) DMTModulus image C) Adhesion image: The
exosomes appear as circular biconvex vesicular structures. The DMTModulus and adhesion images of exosomes show explicit sub-structures at the centre
of the vesicles (arrows). D) Schematic cross-section following the line in the indicated exosome in C). C) FACS analysis of B-cell antigens on CLL exosomes
prepared from primary CLL cases by density ultracentrifugation and adsorbed onto 4μm aldehyde-sulphate latex beads and incubated with isotype control,
anti-HLA-A, B, C or CD19 antibodies followed by FITC-conjugated secondary antibody. Mean fluorescence intensities are plotted (mean ± standard error of
mean (S.E.M.) (n = 9)). D) Representative analysis showing surface expression of CD81, HLA-DR, CD37, and integrin α4 (ITGA4) in CLL derived exosomes
coupled to aldehyde-sulphate latex beads. Binding of FITC-conjugated isotype controls are included for comparison. E) Immunoblot analysis of CLL derived
exosomes: Lysates from CLL exosome were probed for abundance of HLA-DR, MHC, IgM, Gp96, Lyn kinase, TSG 101 and Calnexin. Images are
representative of analyses of 3 cases.WCE-Whole cell extract.
doi:10.1371/journal.pone.0141429.g001
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morphological characteristics to those isolated by ultracentrifugation (Fig 1A, lower panel).
Finally, atomic force microscopy (AFM) was used to generate three-dimensional images for
more detailed morphological analyses of the exosomes in their native state. Fig 1B shows con-
firmation of the biconvex spherical structure that is characteristic of exosomes, and of their
diameter (93.5 ± 11.6 nm) and height [74.8 ± 11.2 nm (n = 30)] dimensions.
Exosomes exhibit surface characteristics that reflect their cells of origin.[21] To examine the
characteristics of CLL-derived exosomes, we initially adsorbed them on to aldehyde sulphate
latex beads and then labelled with antibodies directed against CD19 and MHC class I for analy-
sis by flow cytometry. Fig 1C demonstrates that exosomes derived from primary CLL samples
(n = 9) show enhanced expression of these B-cell markers. Further analysis of these exosomes,
using a broader panel of antibodies, showed that they also express HLA-DR (MHC class II)
and the tetraspanins CD81 and CD37 (Fig 1D). Such antigenic expression is characteristic of
both exosomes in general and of B-cells.[22] In a specific instance, where the CLL cells
expressed ITGA4, the secreted exosomes also expressed this integrin on their surface (Fig 1D,
lower left panel). The CLL-derived exosomes were then subjected to Western blot analysis
(Fig 1E). Here we confirmed expression of TSG-101, MHC classes I and II, IgM, and Lyn
kinase. Notably, the endosplasmic reticulum (ER) associated proteins Gp96 and Calnexin were
absent, confirming that the CLL-derived exosomes were not contaminated with other mem-
brane-derived structures, but encapsulate proteins that are characteristic of both the donor
cells and of multivesicular bodies in general (MVB).[23]
In summary, we demonstrate that CLL cells produce vesicles whose physical and morpho-
logical characteristics reflect their cellular origin and an exosomal phenotype.
CLL-derived exosomes are internalised by stromal cells and localise to
late endosomes
Intercellular communication by exosomes is accomplished by the uptake of these vesicles into
recipient cells by processes such as endocytosis,[24, 25] resulting in the transfer of their molec-
ular content and subsequent modulation of recipient cell behaviour.[12, 26] To model CLL cell
interaction with the microenvironment we used the normal human bone marrow stromal cell
line HS-5. We labelled purified exosomes from primary CLL (n = 3 cases) cell culture medium
with a green fluorescent lipophilic dye (PKH67) as previously described.[24] These labelled
exosomes were added to adherent HS-5 cultures in serum-free media, and after 2-hour incuba-
tion at 37°C the cells were washed, and then further cultured overnight with the addition of
fresh medium. Next, the HS-5 cells were fixed, permeabilised, and stained with antibodies that
recognise either TSG-101 (a marker of the endosomal sorting complex (ESCRT) required for
transport), or Lamp-1 (a marker of late endosomes) [24, 27], and analysed by fluorescence
microscopy (Fig 2). HS-5 cells incubated with PKH67-labelled CLL exosomes showed a distinct
patchy intracellular green fluorescence pattern within their cytosol, a pattern of staining that
was not present in the control HS-5 cells exposed to an equivalent amount of free PKH67 dye
(lower left panel, Fig 2). This suggests that the HS-5 cells internalise the labelled exosomes. In
co-localization studies, we observed that the internalised exosomes co-associated with Lamp-1,
but not TSG101 (right hand panels), suggesting that the exosomes were transported to endoso-
mal organelles within the HS-5 cells. Similar results were obtained for exosomes sourced from
the MEC-1 cell line culture medium (not shown). Taken together, these results show intracellu-
lar sorting of internalised exosomes by HS-5. PKH67-labelled exosomes are trafficked to late
endosomes as confirmed by co-localization of PKH67and Lamp-1 in treated HS-5 cells.
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Uptake of CLL exosomes, derived from in vitro and in vivo sources, by
recipient stromal cells has functional consequences and promotes cell
proliferation
Release of exosomal contents, into recipient cells should lead to altered gene expression and
result in modulation of cellular behaviour. To study the consequences of exosomal uptake,
we incubated HS-5 cells with MEC-1 derived exosomes and addressed the effects on gene
expression patterns of recipient stromal cells. In this experiment, we used an RT2 Profiler PCR
array (see methods) to detect alterations in expression of 84 selected genes critical for pathways
such as cell proliferation, apoptosis, and the cell cycle in exosome-treated and control HS-5
cells. Among the genes differentially expressed, ATM (3.1-fold), c-fos (2.36-fold), ITGAV
(2.05-fold), TNFRSF25 (2.25-fold) and PNN (2.92 fold) were overexpressed, while E2F1
(-1.45) and BAD (-1.25) were downregulated in exosome-treated HS-5 cells. The expression of
the selected genes in treated and untreated HS-5 cells and fold changes in all 84 genes are
detailed in S2 File. Additionally, we sought to confirm the upregulated expression of c-fos and
ATM by independent RT-qPCR analysis of cDNA from exosome-treated cells compared to
untreated cells ‘spiked’ with an equivalent amount of exosomes. As shown in Fig 3A, HS-5 cells
incubated with exosomes derived from cell culture supernatants of both MEC-1 cells and pri-
mary CLL cells (n = 3) significantly upregulated c-fos expression (p = 0–01). Although there
Fig 2. CLL-derived exosomes are internalised by stromal cells and localise to late endosomes.
Exosomes purified from CLL cell culture supernatants were labelled with the lipophilic dye PKH67. HS-5
stromal cells were cultured in the absence (control) or presence of fluorescent-labelled exosomes for 24hrs.
Paraformaldehyde fixed HS-5 cells were permeabilised and stained for Lamp-1 or TSG-101, followed by
FITC-conjugated secondary antibody and visualised by fluorescence microscopy (original magnification,
×100). Nuclei were stained using DAPI. Internalised exosomes co-localise with Lamp-1, a marker for late
endosomes but not with TSG-101. A) Exosomes were internalised by HS-5 Cells and visualized for PKH67
(green), Lamp-1 (red) and DAPI (blue). Co-localisation of Lamp-1 and PKH67 appear in yellow. B) HS-5 Cells
were visualized for PKH67 (green), TSG-101 (red) and DAPI (blue) and do not show co-localisation C) As
controls. HS-5 cells were stained with free PKH67 dye without exosomes or antibody isotype control to
exclude non-specific binding. (Scale bars: 10μm).
doi:10.1371/journal.pone.0141429.g002
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was a similar increase in ATM levels in HS-5 cells on exosomal incubation and uptake from
both sources, MEC-1 derived exosomes were relatively better at upregulating the expression
(p = 0.01 vs 0.07). As exosome-spiked HS-5 cells were used as control, this confirms that
altered expression of these genes was not merely due to passive transfer of exosomal mRNA
content. To further examine the functional consequence of c-fos gene overexpression, HS-5
cells were treated for 24 hrs with exosomes isolated from MEC-1 or CLL cells for 24hrs.
Nuclear extracts were assessed by an ELISA based c-fos activation assay (Fig 3B). Compared to
untreated HS-5 cells, MEC-1 exosome treated cells showed a significant increase in c-fos acti-
vation (p = 0.01). Although not quite reaching significance, a similar trend (p = 0.06) was also
noted for cells treated with exosomes derived from primary CLL cells. These results indicate
that exosome uptake actively affects the transcriptome of stromal cells with functional
consequences.
The importance of direct interactions between CLL cells and stromal cells for tumour cell
survival and proliferation is well documented.[28] The contribution and importance of exo-
somes, and their cargo, in inter-cellular communication is less clear. To address the physiologi-
cal relevance of our findings above, we sought to examine the effects of CLL exosomes on
stromal cell proliferation. Fig 3C shows that HS-5 cells cultured in the presence of CLL-derived
exosomes showed enhanced proliferation in comparison with control cells (p = 0.004).
We next compared the effects of exosomes derived from the plasma of CLL patients with
that from normal subjects (n = 3 each). In keeping with the result obtained with in vitro derived
exosomes, in vivo sourced CLL exosomes positively influenced stromal cell proliferation
(Fig 3C, p = 0.006) whereas exosomes derived from normal plasma had no effect.
Fig 3. CLL derived exosomesmodulate the gene expression profiles of HS-5 cells and alter the rate of their proliferation. (A) HS-5 cells were treated
with MEC-1 exosomes for 24hrs and a pathway array analysis of cellular RNA was performed (S2 File). Untreated HS-5 cells ‘spiked’ with equivalent doses
of MEC-1 exosomes served as control. Validation of c-fos and ATM expression level changes determined by additional RT-qPCR is shown. Error bars
represent ± S.E.M. of three independent experiments. p values indicating level of significance are shown. (B) Exosomes influence c-fos activation in recipient
cells: c-fos heterodimer complex DNA binding activity was detected using an ELISA transcription factor assay kit (Active Motif). HS-5 cells were cultured
alone or with exosomes as indicated. Nuclear extracts fromMEC-1 and CLL exosome treated HS-5 cells show increased c-fos activation (p = 0.009 and
p = 0.06 respectively). (C) HS-5 cells plated at a density of 3000 cells/well were incubated in the absence or presence of exosomes derived from primary CLL
cell culture medium (CLL CM), CLL patient plasma or normal healthy donor plasma, (150ug/ml) and proliferation measured after 48 hrs using the CyQuant
assay. Paired t-test was used to calculate p values. All data represent mean ± S.E.M of triplicate experiments.
doi:10.1371/journal.pone.0141429.g003
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In conclusion, our studies provide proof that CLL cells secrete exosomes, both in vitro and
in vivo, and that these exosomes have comparable effects on stromal cell proliferation. As sev-
eral studies have proposed that transfer of exosomal microRNA may modulate the biological
function of the recipient cells [29], [30], [14], [31], we next investigated the microRNA cargo of
these CLL derived exosomes.
CLL exosomes selectively encapsulate miRs and are enriched in miR-
202-3p
Previous studies have shown that exosomes encapsulate functional mRNAs, miRs and proteins
that reflect their cell of origin [5, 10, 32, 33]. Given the importance of miRs in CLL pathobiol-
ogy [17, 19, 34], we hypothesised that CLL derived exosomes should contain unique miRs that
are reflective of CLL cell content and additionally relevant for disease biology. To this end, total
RNA was extracted from paired exosomal preparations and parental cells from six CLL cases.
Initial analysis of this extracted RNA showed that exosomes were more abundant in small
RNAs compared to total cellular RNA, and also lacked 18S and 28S ribosomal RNA (Figure C
in S1 File). We next performed parallel miR expression profiling of exosomal (180 ng) and
total cellular RNA (1μg) using an LNA array platform (consisting of 899 human miRs) as
detailed in the Supplementary section (S3 File).
In order to visualize the differences between the two sources we analysed fold differences
and generated a volcano plot. In general, the miR content of the exosomes reflected the content
in the parental cells with enrichment of miRs that are relevant in CLL cell biology. However,
we found that certain candidate miRs are specifically enriched or counter-selected in exosomes
including miR-202-3p, miR-1290, and miR-628-3p but are less abundant in the parental cells
(Fig 4A).
To validate these findings of the LNA array, we performed RT-qPCR analysis of CLL cells
and the derived exosomes for all samples (Fig 4B). Due to the lack of a suitable miR shared by
both cellular and exosomal samples that lends itself as an optimal normalisation control, mea-
surement of miRs with the RT-qPCR protocol was performed using the mirVanaTM miRNA
Reference Panel v9.1 (Ambion, UK) which allows quantitation based on the generation of stan-
dard curves generated for specific miR sequences. We selected miR-29a, miR-29b, miR-26a,
and let-7g as these species are highly expressed in CLL cells and are relevant for disease biology
[35]. Importantly, miR-1290, miR-628-3p, and miR-202-3p were enriched within the exosomal
RNA (Fig 4A). As high levels of miR-202-3p were seen in all six exosomes samples compared
to parental CLL cells (Fig 4C) in the LNA array, we focused on miR-202-3p for further studies.
A further analysis of miR-202-3p expression in paired exosomal RNA and parental cells by
RT-qPCR confirmed significant enrichment of miR-202-3p in contrast to other miRs that are
equally abundant in cells and exosomes. Fig 4D shows fold change in specific miR expression
in exosomes vs. cells in two representatives CLL cases. Taken together, these data show that
CLL exosomes carry a miR cargo, which largely represents their cell of origin, but are also selec-
tively enriched for miR-202-3p.
CLL exosomes alter the levels of miR-202-3p and its target Sufu mRNA
in recipient cells
To study whether encapsulated miRs in CLL exosomes are transferred to recipient cells we
incubated HS-5 cells with MEC-1 derived exosomes, as miR-202-3p expression levels in exo-
somes derived fromMEC-1 cells or primary CLL cells are quantitatively similar (not shown).
Fig 5A shows that such incubation results in a statistically significant increase in miR-202-3p
levels (p = 0.02) in treated HS-5 cells compared to untreated controls. Next, we focused on a
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known target of miR-202-3p, namely Sufu a regulator of the Gli-Hedgehog signalling pathway
with an established role in the oncogenesis of CLL.[36] Our selection was based on interro-
gation of the miRWalk database for miRNA-target interactions.[37, 38] In fact, both Sufu
mRNA transcript variants 1 and 2 contain miR-202 target sequences in their 3’ untranslated
region (UTR) (Figure D in S1 File).
We show that in HS-5 cells treated with MEC-1 exosomes, there is a significant reduction in
Sufu mRNA expression (Fig 5B; p = 0.001). Our PCR primers were designed to amplify both
variants of Sufu mRNA. This data supports an effect of exosomal miR-202-3p on target HS-5
cellular Sufu mRNA.
Fig 4. MicroRNA profiles and RT-qPCR of purified exosomes and parental CLL cells. A) A volcano plot of LNA array miRNA profiles of CLL cells vs
exosomes samples is depicted. The x-axis shows the Log2 fold-change in miRNA expression between cellular cases and exosomes. The y-axis shows the
-Log10 of the p value for each miRNA. Expressed miRs that are statistically significant between the two groups appear above the line (p < 0.05). B) The miRs
let-7g, miR-21, miR-29a, miR-29b, and miR-26a were selected for validation of LNA array by RT-qPCR analysis (n = 5). Data represent mean ± S.E.M of
triplicate experiments. C)miR-202-3p is enriched in exosomes compared to parental cells in the LNA array data (mean ± S.E.M). D) Fold change of miR
expression in exosomes vs cellular CLL samples showing the enrichment of miR-202 by RT-qPCR in two representative cases.
doi:10.1371/journal.pone.0141429.g004
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Indeed, HS-5 cells tranfected with a miR-202-3p mimic, but not a scrambled oligonucleo-
tide control, showed a concentration-dependent reduction in Sufu mRNA levels (Fig 5C). In
addition, there was a corresponding decrease in Sufu protein levels on transfection of HS-5
cells with the miR-202-3p mimic compared to the scrambled control (Figure E in S1 File). To
understand the relevance of miR-202-3p expression in CLL, we performed an RT-qPCR analy-
sis of cellular RNA in CLL cells, and compared this with that in normal B-lymphocytes. Fig 5D
shows that CLL cells contain significantly lower levels of miR-202-3p compared to normal B-
cells. We next compared miR-202-3p levels in exosomes derived from CLL cells (n = 9) and
normal B-cells (n = 3) and found variable expression by RT-qPCR analysis. The exosomes
from normal B-cells do contain slightly higher levels of miR-202-3p compared to the CLL
cohort (Figure F in S1 File) and likely reflect the higher levels in normal B-cells compared to
Fig 5. Expression of miR-202-3p and its target Sufu mRNA in CLL cells. (A) HS-5 cells incubated with MEC-1 exosomes for 24 hrs show increased
expression of miR-202-3p by RT-qPCR analysis. The results represent the findings of three independent experiments. (B) HS-5 cells incubated with MEC-1
exosomes for 24 hrs show decreased expression of Sufu, one of the miR-202-3p targets, by RT-qPCR analysis. The bar graphs are derived from three
independent experiments. (C) RNA extracted from HS-5 cells transfected overnight with a synthetic miR-202-3p mimic or scrambled control, was subjected
to RT-qPCR to assess Sufu mRNA expression. (D) RT-qPCR of miR-202-3p, using RNA prepared from CLL cells (n = 19) or normal B cells (n = 4). Box plots
show the expression level of miR-202-3p relative to a miR-U6B control for normalisation. (E) Primary CLL cell lysates (n = 12) were subjected to RT-qPCR
analysis for miR-202-3p and Sufu mRNA expression levels, normalised to RNU6 and GAPDH expression respectively, and show statistically significant
inverse correlation. Plotted data represent mean of experiments performed in triplicate. (F) Sufu mRNA expression, using RT-qPCR and GAPDH as
reference, in primary CLL cells of 12 unmutated and 10 mutated CLL cases is shown. Data demonstrate relatively higher (p = 0.05) levels of Sufu expression
in the IgVH unmutated cohort. The expression in individual cases represents the mean of triplicate measurements.
doi:10.1371/journal.pone.0141429.g005
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CLL cells as noted above (Fig 5D). This would suggest that in contrast to normal B-cells, there
is a significant active and deliberate packaging of miR-202-3p into CLL exosomes. Further-
more, miR-202-3p expression showed a significant negative correlation with Sufu mRNA levels
in CLL cells (Fig 5E; R = -0.70, p = 0.01). These data support linked tumour-suppressive and
oncogenic roles in CLL for miR-202-3p and Sufu respectively. To evaluate the relevance of
Sufu expression in disease biology, we subjected primary cell lysates from 12 IgVH unmutated
and 10 mutated CLL cases to RT-qPCR analysis for Sufu mRNA expression using GAPDH
mRNA for reference. IgVH umutated CLL cases, with reported poorer outcomes, have rela-
tively higher levels of Sufu expression (Fig 5F; p = 0.05).
Expression of selected miRs in exosomes derived from CLL patient
plasma
To obtain confirmation of selective enrichment miR levels in exosomes derived from in vivo
sources, we compared the expression of miR-202-3p in exosomes derived from CLL and
healthy donor plasma by RT-qPCR analysis and show that there are significantly lower levels
in the latter (Fig 6A; p = 0.03, n = 3 cases). This was also evident for miR-29a and miR-21
which were relatively higher in CLL plasma derived exosomes compared to those sourced from
healthy donor plasma (Fig 6B; n = 3 each). This suggests the existence of active regulatory path-
ways that lead to higher expression of selected miRs in CLL exosomes and plasma and may
have utility as biomarkers of disease behaviour.
In conclusion, the relatively higher levels of miR-202-3p in CLL derived exosomes, com-
pared to the parental cells suggests that such selective sequestration into the secreted exosomes
is an active and regulated process, and of likely relevance in disease biology and behaviour.
Fig 6. Expression of miRs 202-3p, 29a, and 21 in exosomes derived from plasma of CLL patients versus normal donors. (A) Exosomes sourced from
plasma obtained from CLL patients or healthy donors (n = 3 each) were subjected to RT-qPCR analysis for absolute levels of miR-202-3p using a standard
curve method. The levels of miR-202-3p are significantly higher in exosomes purified from CLL plasma (p = 0.03). (B) Absolute levels of miR-29a and miR-21
in exosomes harvested from CLL patient and healthy donor plasma (n = 3) were determined by RT-qPCR analysis. Standard curves for miR-29a and miR-21
were generated using the miRVanaTM miRNA reference panel v9.1. Statistical analysis was performed using an unpaired t-test and yielded p values of 0.01
and 0.2 for miR-29a and miR-21 respectively.
doi:10.1371/journal.pone.0141429.g006
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Discussion
In recent years, the versatile role of exosomes in cell-cell communication, in physiological and
pathological states, has attracted a great deal of attention and is of particular relevance in can-
cer.[6, 21, 39, 40] Exosomes shuttle molecules such as proteins, mRNAs and miRs between
cancer cells and their microenvironment to influence disease behaviour. In this study we aimed
to characterise exosomes secreted by CLL cells, examine their potential effects on the microen-
vironment, as well as explore the nature of their miR content.
Our data provide a physical description of exosomes derived from CLL cells. We have puri-
fied these secreted vesicles from supernatants of cultured CLL cells using established protocols
[20] and show that their size (50–100 nm) and morphology are consistent with that of exo-
somes derived from other cell systems. [23] Phenotypic characterisation confirmed that CLL
cell-derived exosomes carry classical exosomal markers such as MHC class I and II molecules,
CD81, and TSG-101, as well as elements unique to CLL cells such as IgM, CD19, Lyn, and the
integrin ITGA4 in a specific instance. Our work can be distinguished from the findings of
Ghosh et al [15] who isolated, and functionally characterised CLL microvesicles, which differ
with respect to their biogenesis and physical characteristics. Whereas microvesicles (100–1000
nm) form by budding from plasma membranes, exosomes are derived from intracellular endo-
somes that fuse to the plasma membrane for release, implying a more active process.[6] Hence,
we chose to focus our efforts on isolation of exosomes that are likely distinct in their molecular
content and function due to their mode of origin.
Earlier studies of microvesicles and exosomes have demonstrated that these vesicles transfer
RNA and protein content to alter recipient cell behaviour.[10, 11, 15] In line with other stud-
ies,[24, 25] we demonstrate that CLL exosomes are taken up by stromal cells and localise to late
endosomes in the recipient cells as evidenced by co-localisation with the specific marker
Lamp-1. It is notable that, as with microvesicles, CLL exosomes actively influence the stromal
cell transcriptome and alter their growth characteristics. Melo et al.[31], show that primary
breast cancer exosomes initiate non-cancerous epithelial cells to form tumours by rapid silenc-
ing of target mRNAs to reprogram the target cell transcriptional profile. We show that CLL
exosomes similarly modify the gene expression profiles of stromal cells. CLL exosomes
significantly increased c-fos and ATM levels in stromal cells that was not merely a reflection of
passive transfer of exosomal mRNAs. c-fos functions as a subunit of a group of dimeric tran-
scription factors collectively referred to as activating protein 1 (AP-1) that are implicated in a
wide range of processes, including proliferation and oncogenic transformation.[41] Hence, we
studied the effects of CLL exosomes derived from CLL culture medium and patient plasma on
proliferation of HS-5 cells. We show that CLL exosomes significantly increase HS-5 prolifera-
tion compared to those derived from normal plasma. This is in line with a previous study by
Gutzeit et al., who showed that exosomes from Burkitt’s lymphoma cell lines enhance prolifera-
tion in recipient cells.[26]
Secretion of exosomes from B-cell lines is well documented but their release from normal or
malignant primary B-cells is less well studied.[42–44] The generation of exosomes is not a con-
stitutive activity of normal B cells, but is induced following activation signals such as IL-4 and
anti-CD40.[45, 46] For our studies, we examined the miR cargo of primary CLL derived exo-
somes given the importance of miRs in CLL biology.[17, 18] Of significance, we show that CLL
exosomes are highly enriched for small RNA species. After the first description of miRs in exo-
somes, [10] numerous groups have analysed their presence in exosomes.[8] Some miRs were
selectively enriched in exosomes, [13, 14] indicating the existence of specific sorting mecha-
nisms [5, 10, 30, 32] that have functional consequences. For example, exosome-contained miRs
from cancer cells activate TLR8, and promote release of interleukin-6 and TNFα, in recipient
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immune cells.[13] We have compared exosomal miRs with CLL cellular miRs using an LNA
array consisting of 899 human miRs. The primary cells used in this study represented subsets
of CLL with different prognostic variables. In our profiling data we found important miRs,
already reported to be of relevance in disease biology, [17, 18, 35] to be equally abundant in
cells and exosomes while other miRs such as miR-202-3p, miR-628-3p, and miR-1290 were
specifically enriched in exosomes.
In our studies, miR-202-3p was consistently enriched in all exosome samples compared to
parental cellular samples. This finding was additionally confirmed by qRT-PCR analysis of
selected miR species within exosomes and cellular RNA. These findings are analogous to
another study where it was shown that acute myeloid leukaemia (AML) cells generate exo-
somes that are enriched for miR-146.[40] Similarly, Fabbri et al.,[13] find enrichment of miR-
21 and miR-29a in exosomes derived from supernatants of lung cancer cells. The enrichment
of miR-202-3p in implies the existence of specific sorting mechanisms within CLL cells that
dictate the molecular content of released exosomes.
Deregulation of miR-202-3p is well documented in various tumour types such as cervical,
breast, colorectal and gastric cancers.[47, 48] A tumour suppressor role of this miR is suggested
by studies showing that it is significantly downregulated in follicular lymphoma compared to
follicular hyperplasia.[48, 49] Increased expression of miR-202-3p is generally associated
with cell differentiation. With respect to CLL, exosomal release of miR-202-3p from malignant
cells into the microenvironment is likely to result in a decrease of its anti-tumorigenic effect.
Increased expression of Sufu, a target of miR-202-3p and a negative regulator of Hh signalling,
is associated with poor prognosis in CLL.[36] In our study, the expression of Sufu was variable
among the CLL cases used but did show a negative correlation with miR-202-3p expression. In
addition, we observed a trend for higher levels of expression for Sufu in IgVH unmutated CLL
cases, a finding that is in agreement with previous reports of its overexpression in patients with
poor prognosis and worse outcomes. Thus, our data suggest that CLL cells specifically package
miR-202-3p in order to influence cellular Sufu levels and affect disease behaviour.
In conclusion, we demonstrate that the unique content of secreted exosomes has implica-
tions for behaviour of both CLL cells and the cells in the microenvironment. The diverse exoso-
mal cargo of CLL exosomes presents an inherent challenge in assigning a specific functional
outcome to the transfer of an individual exosomal miR, mRNA, or protein transcripts. Never-
theless, secretion of exosomes likely has an important role in disease biology and cell behaviour
in CLL. In particular, we suggest that the biology surrounding miR-202-3p as a tumour sup-
pressor in CLL is worthy of further investigation. In addition, the role of exosomes and their
cargo as potential biomarkers for CLL disease behaviour, and sequestration of specific drugs
and indeed monoclonal antibodies (viz. Rituximab) by such microvesicles contributing to drug
resistance, may be of relevance and requires further studies.
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